Você procurou por: mds (Dinamarquês - Inglês)

mds nordion
• mds nordion

mds nordionorphan europe
marketing authorisation holder

dosering ved mds/mpd
posology for mds/mpd

mds/mpd (startdosis 400 mg)
mds/mpd (starting dose 400 mg)

hvis du behandles for mds/mpd:
if you are being treated for mds/mpd:

kliniske undersøgelser vedrørende mds/mpd
clinical studies in mds/mpd

cml i kronisk fase, mds/ mpd og
chronic phase cml, mds/ mpd and gist

det græske sprog skal indføres i mds.
the greek language will have to be introduced into the mds.

mds felt-effekt transistor med to elektroder
dual-gate mos field-effect transistor

patienter med sekundær mds blev ekskluderet fra studiet.
patients with secondary mds were excluded from the study.

myelodysplastiske/myeloproliferative sygdomme (mds/mdp).
myelodysplastic/myeloproliferative diseases (mds/mpd).

sagerne var typiske for sekundært mds/cancerbehandlingsrelateret aml.
the cases were typical of secondary mds/cancer therapy-related aml.

cytogenetiske anomalier og progression til mds/aml hos patienter med saa
cytogenetic abnormalities and progression to mds/aml in patients with saa

cml i kronisk fase, mds/mpd (startdosis 400 mg)
chronic phase cml, mds/mpd (starting dose 400 mg)

der er ingen kontrollerede forsøg med pædiatriske patienter med mds/mpd.
there are no controlled trials in paediatric patients with mds/mpd.

derudover er yderligere 24 patienter med mds/mpd beskrevet i 13 publikationer.
in addition a further 24 patients with mds/mpd were reported in 13 publications.

mds og leukæmi er naturlige komplikationer til sygdommen, og forbindelse til filgrastimterapi er ikke afklaret.
mds and leukaemias are natural complications of the disease and are of uncertain relation to filgrastim therapy.

tpo- receptorstimulatorer kan i teorien stimulere progression af eksisterende hæmatopoietiske maligniteter eller mds.
for tpo receptor stimulators there is a theoretical concern that they may stimulate the progression of existing haematopoietic malignancies or mds.

den anbefalede dosis af glivec er 400 mg/dag til voksne patienter med mds/mpd.
the recommended dose of glivec is 400 mg/day for adult patients with mds/mpd.

i dette studie indgik 7 patienter med mds/mpd, som blev behandlet med 400 mg glivec daglig.
this study included 7 patients with mds/mpd who were treated with glivec 400 mg daily.